Letrozole in Uterine Leiomyosarcoma
Condition(s):Uterine LeiomyosarcomaLast Updated:February 22, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Uterine LeiomyosarcomaLast Updated:February 22, 2024Recruiting
Condition(s):LeiomyosarcomaLast Updated:March 7, 2024Recruiting
Condition(s):LeiomyosarcomaLast Updated:November 9, 2023Recruiting
Condition(s):LeiomyosarcomaLast Updated:March 15, 2024Completed
Condition(s):Leiomyosarcoma MetastaticLast Updated:February 4, 2021Unknown status
Condition(s):Uterine LeiomyosarcomaLast Updated:November 18, 2015Withdrawn
Condition(s):LMS – Leiomyosarcoma; Uterine LeiomyosarcomaLast Updated:March 5, 2024Recruiting
Condition(s):LeiomyosarcomaLast Updated:April 18, 2017Completed
Condition(s):Metastatic LeiomyosarcomaLast Updated:January 29, 2019Completed
Condition(s):Uterus Leiomyosarcoma; Soft Tissue LeiomyosarcomaLast Updated:January 26, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.